Curriculum for EMEI 2024
Clinical Training in Environmental Medicine

The recorded lectures include 30+ hours of content:

Module 1:

Environmental Medicine, Toxicology & Body Burden: An Introduction- 1 hr.

Module 2:

Taking an Environmental Exposure History- 1 hr.

Module 3:

Laboratory Testing for Toxin and Toxicant Exposure: Toxic Metals- 2 hrs.

Module 4:

Laboratory Testing for Toxin and Toxicant Exposure- Testing for POPs, Plasticizers, Pesticides and Solvents- 2 hrs.

Module 5:

Using Databases to Evaluate Exposure and Retention- 1 hr.

Module 6:

Sources of Exposure, Assessment, Avoidance, and Treatment: Plastics, PFAS, and PDBE- 2 hrs

Module 7:

Sources of Exposure, Assessment, Avoidance, and Treatment: Metals (Mercury, Arsenic, Lead, Cadmium, Aluminum, Gadolinium, Thallium, Copper)- 7 hrs

Module 8:

Sources of Exposure, Assessment, Avoidance, and Treatment: Air Pollution, Pesticides, PCBs, Dioxins, and Solvents- 6 hrs

Module 9:

Biotransformation: Phase I, II, III and Nutrients for Biotransformation- 4 hrs.

Module 10:

Mold and Mycotoxins- 1 hr.

Module 11:

Climate Change and Health- 1 hr.

Module 12:

Endocrine Disruptors- 1 hr.

Module 13:

Cardiovascular Disease- 2 hrs.

Module 14:

Immunotoxicity- 1 hr.

Module 15:

Diabetes and Obesity- 2 hrs.

Module 16:

EMF/EMR Evaluation and Diagnosis of Electrosensitivity- 1 hr.

Module 17:

EMF/EMR Effects and Treatment- 4 hrs.

Exposure Sources-Air, Water, Soil contamination and Laboratory Assessment of Exposure, Avoidance, Treatment

• Polycyclic aromatic hydrocarbons, metals, nanoparticles, solvents, volatile organic compounds, pesticides, PCBs
• PBDEs, PFAS, plastics (BPA, phthalates, bisphenols, nonylphenols)

Biotransformation of Toxicants in Human Body

• Phase I- nutrients necessary/methylation and single nucleotide polymorphism effect/toxicant activation and effect of toxicants on hormone and drug metabolism.
• Phase II-nutrients needed/ single nucleotide polymorphism effect/ toxicant activation and effect of toxicants on hormone and drug metabolism
• Phase III- renal and hepatic anion transport and multidrug resistant protein transport

Climate Change

1. Infectious disease
2. Toxicant and toxin exposure after dramatic weather events and exposure to PM2.5

Systemic Effects: Basic mechanisms of toxicant-induced disease, specific toxicants and conditions linked to their exposure

• Neurotoxicity
• Immunotoxicity (includes cancer and autoimmune disease)
• Endocrine Disruption
• Women’s Health (infertility, endometriosis, PCOS, menopause)
• Men’s Health (infertility, low testosterone, prostate conditions)
• Environmental Cardiology

Water-Damaged Building Exposure/Mold and Mycotoxins

• Signs symptoms and presentation of mold exposed patients
• Toxicology of mycotoxins, evaluation and assessment of patient and their home/work environment
• Treatment of Mold-Related Illness

Electromagnetic Fields/Electromagnetic Radiation Exposure

• Presentation of EMF/EMR exposure and electrohypersensitivity
• Appropriate diagnosis, interventions and recommendations for avoidance

Nutritional Support for Environmental Exposure

• Overview of nutrients utilized in toxicant metabolism
• Assessment of nutrient sufficiency using laboratory testing
• Nutrient replacement utilizing specific supplementation and dietary recommendations

EMEI Founding Directors & Instructors

Anne Marie Fine, NMD, FAAEM

Dr. Fine NMD, FAAEM is a licensed and board-certified naturopathic physician with a focus in Environmental Medicine. She obtained her doctorate in Naturopathic Medicine from the Sonoran University of Health Sciences and has held licenses to practice medicine in California and Arizona for the last twenty years.

She is also the Founder of Fine Natural Products, LLC, a best-selling author, consultant, published author of numerous articles in international peer-reviewed journals, and internationally recognized speaker. Dr. Fine is a member and fellow of the American Academy of Environmental Medicine, and science advisor for the non-profit MadeSafe.org. As well, she is Adjunct Faculty at the Sonoran University of Health Sciences where she teaches Environmental Medicine.

Dr. Fine is a former CPA and financial executive who graduated from the Mendoza School of Business at the University of Notre Dame.

Lyn Patrick ND

Dr. Patrick ND graduated from Bastyr University in 1984 with a doctorate in naturopathic medicine and has been in private practice as a state licensed naturopathic physician in Arizona and Utah for 35 years.

She is a published author of numerous articles in peer-reviewed medical journals, a past Contributing Editor for Alternative Medicine Review, and recently authored a chapter in the newly released textbook Clinical Environmental Medicine (Elsevier 2019). She speaks internationally on environmental medicine, nonalcoholic fatty liver disease, endocrine disruption, metal toxicology and other topics. She is currently Faculty for the Metabolic Medicine Institute Fellowship in collaboration with George Washington School of Medicine and Health Sciences.

She is a planner and faculty member for ACAM and the MMI Fellowship continuing medical education modules, lecturing in the area of chelation and metal toxicology. She is also a founding partner and presenter at the Environmental Health Symposium, an annual international environmental medicine conference based in the United States.

Tim Guilford, MD

Dr Guilford was board certified in ENT surgery in 1978 after attending Johns Hopkins University for his undergraduate degree, the University of Texas Medical Branch for medical school, 2 years of general surgery at Johns Hopkins Hospital and the Univ of Michigan for his ENT training. His clinical practice included an interest in complementary medicine and he also was the director of a clinical laboratory specializing in in-vitro allergy and viral immunology testing (1982 -1992). Dr. Guilford’s study of the role that glutathione plays in the basic mechanism of many diseases led to his formulating a liposome encapsulation of reduced glutathione, ReadiSorb® Glutathione. A list of his publications and research can be found at DrGuilford.com.

EMEI 2024 Clinical Training in Environmental Medicine CME Information

Release date: 12/15/2023
Expiration date: 12/15/2024

Target Audience

This activity is intended to meet the needs of physicians and other healthcare professionals.

Learning Objectives

Upon completion of the educational activity, participants should be able to:

• • • Describe the common signs and symptoms of toxicant exposure and body burden as they present in the average patient.
    • Categorize the most likely classes of toxicants for the patient based upon the patients’ signs, symptoms and diagnosis.
    • Determine which, if any, laboratory measurements would be appropriate in the workup of a toxicant-exposed patient.
    • Identify environmental sources of toxicant exposure in a patient’s everyday environment and avoidance strategies for those exposures.

Method of Participation

Statements of credit will be awarded based on the learner’s participation, completion of all modules and post test questions, and submission of the activity evaluation at the conclusion of this activity.  A statement of credit will be available for print directly upon completion. If you have questions about this CE activity, please contact AKH Inc. at [email protected].

CE Credit Provided by AKH Inc., Advancing Knowledge in Healthcare. This activity is jointly-provided by AKH Inc., Advancing Knowledge in Healthcare and EMEI, LLC.

In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and EMEI, LLC. AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians

AKH Inc., Advancing Knowledge in Healthcare designates this enduring activity for a maximum of 30.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AAPA Credit Designation Statement

AKH Inc., Advancing Knowledge in Healthcare has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 30.0 AAPA Category 1 CME credits. Approval is valid until 1/13/2022. PAs should only claim credit commensurate with the extent of their participation.

Commercial Support

This activity is not supported by an educational grant.

Disclosures

It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with commercial interests whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are resolved by AKH prior to accreditation of the activity and may include any of or combination of the following: attestation to non-commercial content; notification of independent and certified CME/CE expectations; referral to National Author Initiative training; restriction of topic area or content; restriction to discussion of science only; amendment of content to eliminate discussion of device or technique; use of other author for discussion of recommendations; independent review against criteria ensuring evidence support recommendation; moderator review; and peer review. 

Disclosure of Unlabeled Use and Investigational Product

This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participant’s misunderstanding of the content.

Advisory Board

Jeanne A Drisko, MD, CNS, FACN

Jeanne A Drisko, MD, CNS, FACN is a respected member of the University of Kansas Health System faculty where she has served for more than 20 years as professor and the Hugh D Riordan MD Endowed Chair for Orthomolecular Medicine and Research. Currently, Dr Drisko is professor emeritus. Dr Drisko founded the KU Integrative Medicine program in 1998 and during her tenure as director adhered to the four pillars of the academic institution by providing education, patient care, research, and service to the community and the nation. She developed a fellowship in integrative medicine recognized by the American Board of Physician Specialties with graduating fellows board eligible. Dr. Drisko is widely recognized for her research in integrative medicine practices and has been invited to teach at universities across the world. Patients came first and the integrative medicine clinic practice attracted patients from across the US and many foreign countries. In 2018, Dr Drisko stepped back as director of the KU Integrative Medicine clinic but continues as Director of KU Integrative Medicine Research. She continues scholarly pursuits and publishing in peer-reviewed journals. Dr Drisko is a member of the prestigious Academic Consortium for Integrative Medicine and Health where she served on the steering committee for 13 years and continues as president for Alliance for Natural Health – USA. Because of her integrative medicine expertise, Dr. Drisko has been asked to serve on multiple national committees including the Institute of Medicine committee for complementary and alternative medicine therapies use by the American public, with the report published in 2005.

Frederick S. vom Saal Ph.D

Frederick S. vom Saal Ph.D Curators’ Distinguished Professor Emeritus Division of Biological Sciences 105 Lefevre Hall University of Missouri-Columbia Columbia MO 65211 573-356-9621 [email protected] https://biology.missouri.edu/people/vom-saal Dr. Frederick vom Saal is a Curators’ Distinguished Professor Emeritus of Biology at the University of Missouri-Columbia (MU). Prior to attending graduate school he taught biology as a Peace Corps Volunteer in both Somalia and Kenya. As a professor at MU he served on the National Academy of Sciences Committee on Hormonally Active Agents in the Environment, is an elected fellow of the American Association for the Advancement of Science, and is a recipient of the Heinz Foundation Award in Environmental Science, the Upstream Award from the Jenifer Altman Foundation, the Environmental Health Hero Award from the CleanMed Association, and the University of Missouri Alumni Association Faculty Award. He has served on numerous editorial boards of scientific journals and both US and EU research review panels. His research has focused on the long-term effects of fetal exposure to minute differences in endogenous hormones as well as manmade and naturally occurring endocrine disrupting chemicals present in many household products and food. He has testified about the hazards posed by environmental endocrine disrupting chemicals in numerous state legislatures, the US House of Representatives and Senate, and the EU Parliament. He has mentored over 20 graduate students and published over 250 articles and reviews on his research, as well as three books. He has been funded by grants from NIH, other federal agencies and a number of foundations.

URL to access Google Scholar publication list: https://scholar.google.com/citations?user=dtMDE2QAAAAJ&hl=en

Dr. Joseph Pizzorno, ND

Dr. Joseph Pizzorno, ND is a transformational leader in medicine. As founding president of Bastyr University in 1978, he coined the term “science-based natural medicine” which set the foundation for Bastyr to become the first accredited institution in this field anywhere in the world. This validated that medicine which promotes health rather than primarily disease treatment could be credibly taught, researched and practiced. As co-author of the Textbook of Natural Medicine (first edition 1985, 5^th edition 2020) he helped established the scientific foundation for health promotion medicine. With over 100,000 copies sold in 4 languages (over half to MDs), it not only helped reestablish naturopathic medicine as an important part of the healthcare system, but also provided the scientific foundation for the transformational fields of integrative and functional medicine throughout the world.

A naturopathic physician (licensed in WA state since 1975), educator, researcher and expert spokesman, he is Editor-in-Chief of PubMed-indexed IMCJ, Board Chair of the Institute for Functional Medicine, founding board member of American Herbal Pharmacopeia, and a member of the science boards of the Hecht Foundation, Gateway for Cancer Research and Bioclinic Naturals. He was appointed by Presidents Clinton and Bush to 2 prestigious government commissions to advise the President and Congress on how to integrate natural medicine into the healthcare system. He is author or co-author of 6 textbooks for doctors (most recent Clinical Environmental Medicine) and 7 consumer books (Encyclopedia of Natural Medicine [>2 million copies in 6 languages]; most recent, The Toxin Solution).

Leonard A. Wisneski, MD, FACP

Endocrinologist, Integrative Medicine Clinician and National Leader

Integrative Health Policy Consortium (IHPC) Board of Directors, Chair Emeritus

Clinical Professor of Medicine, George Washington University Medical Center

Faculty, Georgetown University and University of Colorado

Email: [email protected]

Leonard A. Wisneski Biography

Dr. Wisneski graduated from Thomas Jefferson Medical College and performed his postgraduate training in the field of Internal Medicine and Endocrinology in the George Washington University healthcare system, where he served as Chief Medical Resident in Internal Medicine. From 1977 until 1997, Dr. Wisneski was the Corporate Medical Director of Marriott International, Inc., and Director of Medical Education at Holy Cross Hospital in Silver Spring, Maryland, an affiliate of George Washington University Medical School and Children’s National Medical Center where he devoted his efforts to teaching the fundamentals of internal medicine, as well as, an integrative, whole person approach to medicine.

Dr. Wisneski is currently engaged in the facilitating a National University Library consortium of integrative health book collections with one of the core collections being The Strauss-Wisneski Indigenous and Integrative Medicine Collection at The University of Colorado Health Sciences Library. He served on the steering committee of the National Coordinating Center for Integrative Medicine whose mission it is to facilitate education of integrative and preventive healthcare. His current passion is serving on the board of directors of The Viktor Frankl Institute of logotherapy, and serving as Chief Medical Officer of Parallel Profile, a genomics testing company. He also has an interest in therapeutic applications involving the endocannabinoid system and is a member of the Society of Cannabis Clinicians and The International Cannabinoid Research Association.

Also see: https://www.linkedin.com/in/leonard-wisneski-9924a47;

http://www.ihpc.org/team/leonard-a-wisneski-md-facp/